Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease-Reference-Cited by-同舟云学术

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

Published:2021-05-15 Issue:3 Volume:15 Page:451-458
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Huang Shang-Chin¹^ORCID,Su Hau-Jyun¹^ORCID,Kao Jia-Horng¹²³^ORCID,Tseng Tai-Chung¹³^ORCID,Yang Hung-Chih¹³^ORCID,Su Tung-Hung¹³^ORCID,Chen Pei-Jer¹²³^ORCID,Liu Chun-Jen¹²³^ORCID

Affiliation:

1. Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei City, Taiwan

2. Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine and Hospital, Taipei City, Taiwan

3. Hepatitis Research Center, National Taiwan University College of Medicine and Hospital, Taipei City, Taiwan

Funder

National Taiwan University Hospital

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

https://pdf.medrang.co.kr/GNL/2021/015/GNL015-03-451.pdf

Reference25 articles.

1. Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008

2. New trends on obesity and NAFLD in Asia

3. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

4. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

5. Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD;Hepatology International;2024-08-08

2. Pre-Existing and New-Onset Metabolic Dysfunctions Increase Cirrhosis and Its Complication Risks in Chronic Hepatitis B;American Journal of Gastroenterology;2024-06-26

3. Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease;European Journal of Gastroenterology & Hepatology;2024-04-26

4. Navigating the Nomenclature of Liver Steatosis: Transitioning from NAFLD to MAFLD and MASLD - Understanding Affinities and Differences;Siriraj Medical Journal;2024-04-01

5. Pre-MASLD: Should it be defined separately?;Hepatobiliary & Pancreatic Diseases International;2024-02